Industries

Consumer

Nike Needs to Find Its Footing Ahead of Earnings

Photo via Richard B. Levine/Newscom

Nike is trying to make a comeback under CEO Elliott Hill, who started in 2024 at a time when the shoe company seemed to veer off course.

2 min read

Photo illustration by Connor Lin / The Daily Upside

Artificial Intelligence

With AI Washing, C-Suite Lets Tech Take the Credit (and the Blame)

Talk about automation is swamping American industries, but are the companies tossing around tech-savvy buzzwords overstating robotic reality?

4 min read
Photo via Jerry Mennenga/ZUMAPRESS/Newscom

Industries

Trump Meets with Farmers as Soaring Fuel, Fertilizer Prices Strain Food Supply Chain

Midwest farmers told the Des Moines Register that they’re already being quoted fertilizer prices that are up 40% from the fall.

2 min read
Photo via Anthony Behar/Sipa USA/Newscom

Healthcare

Merck Preps for End of Keytruda Exclusivity with $6.7B Deal for Leukemia Treatment

The key patent protections on Keytruda, Merck’s immunotherapy treatment that outsold all other prescription drugs last year, ends in 2028.

1 min read

Energy

JPMorgan Warns of ‘National Security Risk’ from Aging Power Grid

Photo via imageBROKER/Jim West/Newscom

The grid is already being tested by the massive demand for data centers to support the artificial intelligence boom.

2 min read

Healthcare

GLP-1 Race Heats Up with Positive Test Results for Next-Gen Eli Lilly Drug

Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

Approximately one in eight Americans are taking medications like Ozempic or Wegovy for weight loss, diabetes, heart disease and more.

2 min read

Media & Entertainment

Wanna Bet? MLB Makes Polymarket Its Official Predictions Market Partner

Photo via Kyodonews/ZUMAPRESS/Newscom

MLB Commissioner Rob Manfred pitched prediction markets Thursday as potentially more immune to illegal behavior than online sportsbooks.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.